Clinical Trial

A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function

Name: A Pharmacokinetic and Safety Study of MY008211A Tablets in Subjects With Impaired or Normal Hepatic Function — clinical trial record (NCT07625618)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This study is a single-center, non-randomized, open-label, parallel, single-dose study to evaluate the PK profile and safety of MY008211A Tablets in subjects with hepatic impairment.

Trial Details

NCT Number	NCT07625618
Lead Sponsor	Wuhan Createrna Science and Technology Co., Ltd
Conditions	Hepatic Insufficiency (MeSH ID: D048550)
Enrollment	24 participants
Start Date	2024-09-20
Primary Completion	2024-12-28 (estimated)
Study Completion	2024-12-28 (estimated)
Updated on ClinicalTrials.gov	2026-06-04